Phase II study of weekly carboplatin/gemcitabine + concurrent thoracic radiotherapy (RT) followed by consolidation carboplatin/gemcitabine for inoperable stage III non-small cell lung cancer (NSCLC).
2015 ◽
Vol 33
(15_suppl)
◽
pp. e18515-e18515
Keyword(s):
Phase Ii
◽